Ramyar Mahdavi, MD
Pulmonary Disease · Glendale, CANPI 1346481645
Payments from drug & device makers
What this record shows
The money is spread across several categories — education (37.9%), food and beverage and travel and lodging — rather than concentrated in one kind of arrangement. 16 manufacturers reported payments, led by Intuitive Surgical at 46.1% of the total.
Across 78 payments — averaging $185.89 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Intuitive Surgical$7K
- Johnson & Johnson$2K
- Olympus America Inc.$2K
- Noah Medical Corporation$2K
- Pulmonx Corporation$433
- Galvanize Therapeutics, Inc$398
- plus $812 from 10 others
Across 9 payments — averaging $17,250 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Galvanize Therapeutics, Inc$155K
What the payments were for
- Consulting fees$2,00814%
- Travel & lodging$3,43924%
- Food & beverage$3,55325%
- Education$5,50038%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Intuitive Surgical | 13 | $6,691 |
| Johnson & Johnson | 17 | $2,245 |
| Olympus America Inc. | 5 | $2,059 |
| Noah Medical Corporation | 8 | $1,861 |
| Pulmonx Corporation | 9 | $433 |
| Galvanize Therapeutics, Inc | 4 | $398 |
| GSK | 11 | $311 |
| Medtronic | 3 | $201 |
| Astellas Pharma US Inc | 1 | $118 |
| Merck | 1 | $30 |
| United Therapeutics Corporation | 1 | $28 |
| Boehringer Ingelheim | 1 | $26 |
| Optinose US, Inc. | 1 | $26 |
| Viatris Specialty LLC | 1 | $26 |
| ANI Pharmaceuticals, Inc. | 1 | $26 |
| Verona Pharma, Inc. | 1 | $21 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Da Vinci Surgical System$6,597
- EVIS EXERA II ULTRASONIC BRONCHOFIBERVIDEOSCOPE$2,008
- Monarch Platform$1,643
- MONARCH$419
- ALIYA SYSTEM$289
- ILLUMISITE$152
- GALAXY$134
- OJJAARA$120
- XOSPATA$118
How this compares
$14,499 in reported general payments places this provider in the 85th percentile of 1,261 pulmonary disease providers in California.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other pulmonary disease in Glendale
- Samuel LouieSacramento$2.8M
- Shyamsunder SubramanianTracy$1.5M
- Toby MaherLos Angeles$1.3M
- Rajkumar DasguptaPasadena$930K
- Hoang leFountain Valley$814K
- Kevin FussellEncinitas$788K
- Revati ShreeniwasStanford$726K
- David PhamWestminster$571K
- Vijay BalasubramanianFresno$529K
- Victor TapsonLos Angeles$514K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.